Tag: Ochsner Kenner Medical Center

Dr. Mary A. Maluccio to Be Featured Guest for CCF’s Luncheon with the Experts

Mary A. Maluccio, MD, MPH, FACS, Professor of Surgery and Medical Director of the New Orleans Louisiana Neuroendocrine Tumor Specialists program, NOLANETS, a strategic partnership between Louisiana State University and Ochsner Medical Center-Kenner,…

Gallium-68 Scan Coming to NOLANETS for Carcinoid and Neuroendocrine Tumor Patients

Dr. Eugene A. Woltering has announced that the Gallium-68 DOTATATE PET/CT scan is going to be available beginning in the summer of 2014 through The New Orleans Louisiana Neuroendocrine Tumor Specialists (NOLANETS) Neuroendocrine Tumor Program at …

BerriHealth Supports Carcinoid and Neuroendocrine Tumor Research

BerriHealth, a leader in providing high-quality black raspberry powder for clinical trials and directly to consumers online, has donated a portion of their 2013 sales to New Orleans Louisiana Neuroendocrine Tumor Specialists (NOLANETS), led by Dr.…

Run for Hope to Benefit Carcinoid Cancer Research and Education

Get your running shoes ready for the 8th ANNUAL RUN FOR HOPE on Saturday, August 4, 2012.  The goal of the run is to raise awareness of carcinoid cancer, provide education, and give hope . . . while raising funds for carcinoid research and education and the …

Carcinoid Cancer Foundation’s May 2011 Symposium Now Online

The Carcinoid Cancer Foundation is pleased to share with you videos from its carcinoid/NET symposium, “Neuroendocrine Tumor Management:  The Era of Personalized Medicine,” held on May 1, 2011 at Mt. Sinai Medical Center in New York City.

Following …

Up-to-the-Minute: News for the Carcinoid and Neuroendocrine Tumor Community

The first device that simultaneously performs PET and MRI scans, a new alpha-emitter-based therapy for NET cancer patients with progressive therapy-resistant tumors, the first–ever randomized virtual clinical trial, over 100  abstracts on carcinoid…

Carcinoid Cancer Foundation Symposium Features Leading NET Cancer Specialists & a Patient Panel

What are the most state-of-the-art treatments for carcinoid and NET cancer patients today?  Join us on May 1st when the Carcinoid Cancer Foundation presents its 14th Annual Symposium, “Neuroendocrine Tumor Management: The Era of Personalized…